Developer docs
API playgroundTry for free, no card

Search company profiles

OptumRx

Full company profile

uuid0009esm

Namestring
OptumRx
Legal namestring
Optum Inc.
Websiteurl
optumrx.com
Company typeenum
Private
Founded yearint
2026
Descriptiontext

OptumRx is the pharmacy benefit management (PBM) and pharmacy services division of UnitedHealth Group (NYSE: UNH), operating as one of the Big Three U.S. PBMs alongside CVS Caremark and Express Scripts. Headquartered in Eden Prairie, Minnesota, OptumRx processes approximately 1.7 billion prescriptions annually and supports nearly 61 million members across health plans, employers, unions, government programs, and individuals. The platform spans a core PBM claims and formulary engine, Optum Home Delivery Pharmacy, Optum Specialty Pharmacy (cancer, autoimmune, MS, viral hepatitis), Optum Infusion Pharmacy, and sub-brands divvyDOSE and Genoa Healthcare, with member-facing digital tools Shop MyScript and Price Wise for cost comparison.

The technology stack leverages AI and machine learning deployed across UnitedHealth Group's 10,000+ AI engineers and 1,000+ AI use cases, applied to real-time pharmacy fraud, waste, and abuse detection, prior authorization automation (reducing median approval times from hours or days to under 10 seconds), and specialty drug management through the Specialty Fusion and Optum Guide programs. OptumRx holds a comprehensive set of accreditations including URAC PBM, URAC Specialty Pharmacy, NCQA Utilization Management, NABP Digital Pharmacy, and LegitScript certifications.

OptumRx historically operated on opaque rebate-retention and spread-pricing models, generating an estimated $100B-$150B annually across the Big Three PBMs. In May 2026 the company launched the industry's first transparent pharmacy care model, replacing drug-price-based pricing with clearly defined monthly per-member fees independent of manufacturers' list prices, with GPO purchasing transitioning to flat service fees by end of 2027. Go-to-market combines direct enterprise sales through UnitedHealth Group's integrated platform, channel partnerships with thousands of retail pharmacies and three PSAOs representing 17,000+ pharmacies, and digital self-serve channels via mobile apps and web portal. Notable customers include UnitedHealthcare, AmeriHealth Caritas (post-PerformRx transition, Jan 2026), Independence Health Group, and partners such as Omada Health on the Weight Engage GLP-1 management program. The company faces ongoing regulatory pressure, including a tentative FTC settlement on insulin pricing (June 2026), a Connecticut insurance regulatory fine, and a legal challenge to Iowa's PBM law.

Short descriptiontext

OptumRx is the pharmacy benefit management and pharmacy services division of UnitedHealth Group, processing approximately 1.7 billion prescriptions annually for nearly 61 million members across health plans, employers, unions, and government programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersIrvine, United States
HQ citystring
Irvine
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacy benefit management, specialty pharmacy services, prescription drug coverage, mail order pharmacy, medication therapy management
Industry5 codes
1Formulary Management & Clinical Pharmacy Programs
CodeHLAEAKAAPrimaryYes
2PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)
CodeHLAEAKALPrimaryNo
3Specialty Pharmacy Benefit Management (Specialty PBM)
CodeHLAEAKAEPrimaryNo
4Pharmacy Benefit Analytics, Reporting & Employer Consulting
CodeHLAEAKAKPrimaryNo
5Claims Processing, Adjudication & Payment Integrity
CodeHLAEAKACPrimaryNo
NAICS code1 code
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
SIC code1 code
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Pharmacy Benefit Management
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Rebate Retention
TypeSubscription Recurring
Description

Historically, Optum Rx generated revenue by retaining manufacturer rebates negotiated through formulary placement. The FTC alleged this model created incentives to favor high-list-price products to maximize rebate revenue.

drugpatentwatch.com
2Spread Pricing
TypeTransaction Fee
Description

PBMs charge employers and health plans different prices than what they reimburse pharmacies, capturing the spread. Estimated $6 billion annually across the Big Three PBMs.

drugpatentwatch.com
3Fee-Based Model (New)
TypeSubscription Recurring
Description

Optum Rx announced transition to a transparent fee-based structure with clearly defined monthly fees per member independent of manufacturers' list prices. Group purchasing set to transition to flat service fees by end of 2027.

bioxconomy.com
4Pharmacy Network Fees
TypeManaged Services
Description

Fees collected from participating pharmacies for network inclusion and from employers/payers for pharmacy benefit administration.

drugpatentwatch.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details4 tiers
1Fee-per-member pricing model replacing drug price-based arrangements
ModelSubscriptionBilling cadenceMonthly
Notes

Clearly defined monthly fees per member independent of manufacturers' list prices. Eliminates spread pricing. Full transparency into Optum Rx fees and GPO payments.

bioxconomy.com
2Group purchasing organization (GPO) flat service fees
ModelSubscriptionBilling cadenceAnnual
Notes

Transitioning group purchasing to flat service fees by end of 2027.

stocktitan.net
3$35 insulin program
ModelUnit PricingBilling cadenceMonthly
Notes

Low-cost insulin available for $35 per month for those without insurance coverage.

4GLP-1 obesity drug coverage
ModelSubscriptionBilling cadenceMonthly
Notes

Coverage through major PBMs including Optum Rx could make GLP-1 medications available for as low as $25/month for some insured patients, though actual coverage depends on employer/plan sponsor decisions.

everydayhealth.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 8 records shown
1Optum Specialty Pharmacy
Description

Specialty pharmacy providing personalized care for complex conditions including cancer, multiple sclerosis, inflammatory arthritis, Crohn's disease, and viral hepatitis with clinical support and medication delivery.

optumrx.com
+7 more records
Core offering1 text field

OptumRx is a pharmacy benefit manager (PBM) that administers prescription drug coverage, formulary design, claims processing, and clinical pharmacy programs for health plans, employers, unions, government programs, and individual members. The company dispenses approximately 1.7 billion prescriptions annually through a network that includes home delivery, specialty, infusion, and retail pharmacy channels, supporting nearly 61 million members. OptumRx also offers specialty pharmacy care for complex conditions, prior authorization automation, and AI-driven fraud detection services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 35% reduction in low-value retrospective audits through AI/ML models
+6 more records
Product overview1 text field

Optum Rx is a pharmacy care services company and one of the 'Big Three' PBMs, offering a platform-plus-modules architecture. The core Optum Rx PBM platform handles approximately 1.7 billion prescriptions annually and serves as the primary interface for prescription management, network pharmacies, and claims processing. This core is supplemented by Optum Home Delivery Pharmacy for mail order, Optum Specialty Pharmacy for complex therapies, and Optum Infusion Pharmacy for IV medications—each functioning as distinct dispensing channels under the same brand umbrella. Adjacent services include divvyDOSE (pre-sorted adherence packaging), Genoa Healthcare (mental health pharmacy), and Weight Engage (GLP-1 management program). Digital tools Shop MyScript and Price Wise provide member-facing cost comparison functionality, while Specialty Fusion and Optum Guide offer specialty drug management and clinical decision support. A transparent fee-based model announced in May 2026 replaces traditional drug price-based pricing across the entire PBM offering, with group purchasing transitioning to flat service fees by end of 2027.

Product and service7 records
1Optum Rx PBM Platform
CategoryPharmacy Benefit Management
Description

Core pharmacy benefit management platform delivering prescription drug coverage, formulary design, network pharmacy access, and claims processing for health plans, employers, and government programs. Processes approximately 1.7 billion prescriptions per year.

2Optum Home Delivery Pharmacy
CategoryMail Order Pharmacy
Description

Mail-order pharmacy service offering free standard shipping, 24/7 pharmacist access, automatic refills, and home delivery of maintenance medications to members across all 50 U.S. states.

3Optum Specialty Pharmacy
CategorySpecialty Pharmacy
Description

Specialty pharmacy dispensing high-cost medications for complex conditions including cancer, inflammatory diseases, multiple sclerosis, and viral hepatitis, with personalized clinical support, temperature-sensitive packaging, and overnight shipping.

4Optum Infusion Pharmacy
CategorySpecialty Pharmacy
Description

Pharmacy service providing intravenous infusion therapies with clinical support and care coordination for patients requiring injectable or IV-administered medications.

5divvyDOSE
CategoryAdherence Pharmacy Services
Description

Medication management service that pre-sorts prescriptions by day and time and delivers them to patients' homes, simplifying complex regimens and improving adherence.

6Genoa Healthcare
CategoryBehavioral Health Pharmacy
Description

Pharmacy services for behavioral health and complex-condition patients, providing medication management and care coordination in partnership with mental health providers and community clinics.

7Transparent Pharmacy Care Model
CategoryPharmacy Benefit Management
Description

Transparent pharmacy care model launched in May 2026 that replaces traditional drug price-based pricing with a fee-based structure offering clearly defined monthly fees per member independent of manufacturer list prices, eliminating spread pricing and providing full transparency into fees and GPO payments.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-05
Description

Omada Health partnered with Optum Rx to participate in its Weight Engage program, providing clinically supervised prescribing and wraparound support services for GLP-1 weight loss medications. This partnership addresses growing demand for GLP-1 drugs amid spotty coverage and adherence challenges, joining existing partners Calibrate and Virta Health. The deal gives Omada relationships with all three largest PBMs.

Strategic tierCoreTypeOthersAnnounced on2026-01-01
Description

Optum Rx took over PerformRx's contracts in 13 states on January 1, 2026, inheriting business that includes Independence Health Group. This represents a significant expansion of Optum Rx's Medicaid managed care footprint.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-12-18
Description

Epic Pharmacy Network, representing 1,400 community pharmacies, started a new cost-based reimbursement model with Optum Rx, as part of Optum Rx's transition to 100% cost-based contracts across its network.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-12-18
Description

Optum Rx partnered with three additional PSAOs representing more than 17,000 pharmacies to achieve 100% transition to cost-based contracts across its network.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CVS Caremark is one of the Big Three PBMs alongside OptumRx, serving comparable employer, health plan, and government clients with formulary management, mail order, and specialty pharmacy services. It is the most direct competitor given nearly identical scale, customer mix, and integrated retail-pharmacy footprint.

TypeDirect peer
Description

Express Scripts is the third member of the Big Three PBMs, offering the same core PBM services as OptumRx — formulary management, home delivery, specialty pharmacy, and claims processing. Recently settled with the FTC on insulin pricing allegations, making it the closest regulatory and competitive peer to OptumRx.

TypeDirect peer
Description

Humana Pharmacy Solutions is the in-house PBM for Humana, primarily serving Medicare Advantage and Part D members. Comparable to OptumRx's government-sponsored segment with overlapping formulary management, prior authorization, and specialty pharmacy capabilities.

TypeDirect peer
Description

Prime Therapeutics is a PBM owned by a consortium of Blue Cross Blue Shield plans, serving health plan clients with formulary and clinical management similar to OptumRx's offerings. Its Blue-affiliated ownership makes it a strong structural peer for health plan-sponsored PBM services.

TypeDirect peer
Description

MedImpact is an independent PBM serving health plans, employers, and government programs with transparent pricing models. Its independence and early transparency positioning make it a direct alternative to OptumRx's fee-based model for clients seeking non-vertically-integrated PBM services.

TypeDirect peer
Description

Navitus is a PBM focused on transparent, pass-through pricing for health plans, employers, and government programs. It competes with OptumRx for clients seeking alternatives to opaque rebate retention models, making it a relevant competitive peer in the transparency segment.

TypeDirect peer
Description

Elixir Rx Solutions is a PBM offering formulary management, mail order pharmacy, and specialty pharmacy services to health plans and employer clients. Comparable to OptumRx in core PBM functionality but at smaller scale, serving as a relevant niche competitor.

TypeEmerging player
Description

Capital Rx is a tech-forward PBM offering a transparent, claims-processing platform (JUDI) for employers, unions, and TPAs. It represents an emerging competitive threat with a technology-native approach to PBM administration that contrasts with OptumRx's vertically integrated model.

TypeEmerging player
Description

SmithRx is a fast-growing, technology-led transparent PBM focused on small and mid-sized employers. While smaller in scale, its modern technology stack and transparent pricing compete directly with OptumRx for the same employer-sponsored book of business OptumRx is courting with its new fee-based model.

TypeBroad incumbent
Description

Amazon Pharmacy is a broad retail and digital pharmacy entrant that has expanded into direct prescription delivery and integrated Amazon One Medical offerings. It does not yet operate as a full PBM but represents a strategic adjacent competitor to OptumRx's home delivery and consumer-facing pharmacy business.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OptumRx

Pharmacy Benefit Managementoptumrx.com

OptumRx is the pharmacy benefit management and pharmacy services division of UnitedHealth Group, processing approximately 1.7 billion prescriptions annually for nearly 61 million members across health plans, employers, unions, and government programs.

What OptumRx does

OptumRx is the pharmacy benefit management (PBM) and pharmacy services division of UnitedHealth Group (NYSE: UNH), operating as one of the Big Three U.S. PBMs alongside CVS Caremark and Express Scripts. Headquartered in Eden Prairie, Minnesota, OptumRx processes approximately 1.7 billion prescriptions annually and supports nearly 61 million members across health plans, employers, unions, government programs, and individuals. The platform spans a core PBM claims and formulary engine, Optum Home Delivery Pharmacy, Optum Specialty Pharmacy (cancer, autoimmune, MS, viral hepatitis), Optum Infusion Pharmacy, and sub-brands divvyDOSE and Genoa Healthcare, with member-facing digital tools Shop MyScript and Price Wise for cost comparison.

The technology stack leverages AI and machine learning deployed across UnitedHealth Group's 10,000+ AI engineers and 1,000+ AI use cases, applied to real-time pharmacy fraud, waste, and abuse detection, prior authorization automation (reducing median approval times from hours or days to under 10 seconds), and specialty drug management through the Specialty Fusion and Optum Guide programs. OptumRx holds a comprehensive set of accreditations including URAC PBM, URAC Specialty Pharmacy, NCQA Utilization Management, NABP Digital Pharmacy, and LegitScript certifications.

OptumRx historically operated on opaque rebate-retention and spread-pricing models, generating an estimated $100B-$150B annually across the Big Three PBMs. In May 2026 the company launched the industry's first transparent pharmacy care model, replacing drug-price-based pricing with clearly defined monthly per-member fees independent of manufacturers' list prices, with GPO purchasing transitioning to flat service fees by end of 2027. Go-to-market combines direct enterprise sales through UnitedHealth Group's integrated platform, channel partnerships with thousands of retail pharmacies and three PSAOs representing 17,000+ pharmacies, and digital self-serve channels via mobile apps and web portal. Notable customers include UnitedHealthcare, AmeriHealth Caritas (post-PerformRx transition, Jan 2026), Independence Health Group, and partners such as Omada Health on the Weight Engage GLP-1 management program. The company faces ongoing regulatory pressure, including a tentative FTC settlement on insulin pricing (June 2026), a Connecticut insurance regulatory fine, and a legal challenge to Iowa's PBM law.

OptumRx firmographics

Firmographics
Name
OptumRx
Legal name
Optum Inc.
Website
https://optumrx.com
Company type
Private
Founded year
2026
Operating status
Operating
Headcount range
1–10 employees
Short description
OptumRx is the pharmacy benefit management and pharmacy services division of UnitedHealth Group, processing approximately 1.7 billion prescriptions annually for nearly 61 million members across health plans, employers, unions, and government programs.
Ownership category
akta.pro rank

OptumRx industry classification

Industry
Product category
Pharmacy Benefit Management
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
SIC
Retail-Drug Stores And Proprietary Stores (5912)
akta.pro primary industry
Formulary Management & Clinical Pharmacy Programs (HLAEAKAA)
akta.pro secondary industries
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL), Specialty Pharmacy Benefit Management (Specialty PBM) (HLAEAKAE), Pharmacy Benefit Analytics, Reporting & Employer Consulting (HLAEAKAK), Claims Processing, Adjudication & Payment Integrity (HLAEAKAC)

Keywords

  • Pharmacy benefit management
  • Specialty pharmacy services
  • Prescription drug coverage
  • Mail order pharmacy
  • Medication therapy management

Where OptumRx is headquartered

Location

Headquarters

HQ city
Irvine
HQ country
United States
HQ region
North America

Offices1 record

Markets served

OptumRx business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Rebate Retention: Historically, Optum Rx generated revenue by retaining manufacturer rebates negotiated through formulary placement. The FTC alleged this model created incentives to favor high-list-price products to maximize rebate revenue.
  2. Spread Pricing: PBMs charge employers and health plans different prices than what they reimburse pharmacies, capturing the spread. Estimated $6 billion annually across the Big Three PBMs.
  3. Fee-Based Model (New): Optum Rx announced transition to a transparent fee-based structure with clearly defined monthly fees per member independent of manufacturers' list prices. Group purchasing set to transition to flat service fees by end of 2027.
  4. Pharmacy Network Fees: Fees collected from participating pharmacies for network inclusion and from employers/payers for pharmacy benefit administration.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyFee-per-member pricing model replacing drug price-based arrangements
SubscriptionAnnualGroup purchasing organization (GPO) flat service fees
Unit PricingMonthly$35 insulin program
SubscriptionMonthlyGLP-1 obesity drug coverage

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

OptumRx product offering

Product offering

Core offering

OptumRx is a pharmacy benefit manager (PBM) that administers prescription drug coverage, formulary design, claims processing, and clinical pharmacy programs for health plans, employers, unions, government programs, and individual members. The company dispenses approximately 1.7 billion prescriptions annually through a network that includes home delivery, specialty, infusion, and retail pharmacy channels, supporting nearly 61 million members. OptumRx also offers specialty pharmacy care for complex conditions, prior authorization automation, and AI-driven fraud detection services.

Product overview

Optum Rx is a pharmacy care services company and one of the 'Big Three' PBMs, offering a platform-plus-modules architecture. The core Optum Rx PBM platform handles approximately 1.7 billion prescriptions annually and serves as the primary interface for prescription management, network pharmacies, and claims processing. This core is supplemented by Optum Home Delivery Pharmacy for mail order, Optum Specialty Pharmacy for complex therapies, and Optum Infusion Pharmacy for IV medications—each functioning as distinct dispensing channels under the same brand umbrella. Adjacent services include divvyDOSE (pre-sorted adherence packaging), Genoa Healthcare (mental health pharmacy), and Weight Engage (GLP-1 management program). Digital tools Shop MyScript and Price Wise provide member-facing cost comparison functionality, while Specialty Fusion and Optum Guide offer specialty drug management and clinical decision support. A transparent fee-based model announced in May 2026 replaces traditional drug price-based pricing across the entire PBM offering, with group purchasing transitioning to flat service fees by end of 2027.

Differentiator

Problem solved

Functional benefit

Brands

  • Optum Specialty Pharmacy: Specialty pharmacy providing personalized care for complex conditions including cancer, multiple sclerosis, inflammatory arthritis, Crohn's disease, and viral hepatitis with clinical support and medication delivery.
  • Optum Infusion Pharmacy
  • Optum Home Delivery
  • divvyDOSE
  • Genoa Healthcare
  • Weight Engage
  • Shop MyScript
  • Price Wise

Products and services

  • Optum Rx PBM Platform Core pharmacy benefit management platform delivering prescription drug coverage, formulary design, network pharmacy access, and claims processing for health plans, employers, and government programs. Processes approximately 1.7 billion prescriptions per year.
  • Optum Home Delivery Pharmacy Mail-order pharmacy service offering free standard shipping, 24/7 pharmacist access, automatic refills, and home delivery of maintenance medications to members across all 50 U.S. states.
  • Optum Specialty Pharmacy Specialty pharmacy dispensing high-cost medications for complex conditions including cancer, inflammatory diseases, multiple sclerosis, and viral hepatitis, with personalized clinical support, temperature-sensitive packaging, and overnight shipping.
  • Optum Infusion Pharmacy Pharmacy service providing intravenous infusion therapies with clinical support and care coordination for patients requiring injectable or IV-administered medications.
  • divvyDOSE Medication management service that pre-sorts prescriptions by day and time and delivers them to patients' homes, simplifying complex regimens and improving adherence.
  • Genoa Healthcare Pharmacy services for behavioral health and complex-condition patients, providing medication management and care coordination in partnership with mental health providers and community clinics.
  • Transparent Pharmacy Care Model Transparent pharmacy care model launched in May 2026 that replaces traditional drug price-based pricing with a fee-based structure offering clearly defined monthly fees per member independent of manufacturer list prices, eliminating spread pricing and providing full transparency into fees and GPO payments.

Quantifiable outcome

  • 35% reduction in low-value retrospective audits through AI/ML models
  • +6 more outcomes

Companies that use OptumRx

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

OptumRx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

OptumRx partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Omada HealthcoreStrategic or Co-development Partner · 5 May 2026Omada Health partnered with Optum Rx to participate in its Weight Engage program, providing clinically supervised prescribing and wraparound support services for GLP-1 weight loss medications. This partnership addresses growing demand for GLP-1 drugs amid spotty coverage and adherence challenges, joining existing partners Calibrate and Virta Health. The deal gives Omada relationships with all three largest PBMs.
  • AmeriHealth Caritas (PerformRx transition)coreOthers · 1 January 2026Optum Rx took over PerformRx's contracts in 13 states on January 1, 2026, inheriting business that includes Independence Health Group. This represents a significant expansion of Optum Rx's Medicaid managed care footprint.
  • Epic Pharmacy NetworkminorChannel Partner/ Reseller/ Distributor · 18 December 2025Epic Pharmacy Network, representing 1,400 community pharmacies, started a new cost-based reimbursement model with Optum Rx, as part of Optum Rx's transition to 100% cost-based contracts across its network.
  • Pharmacy Services Administration Organizations (PSAOs)minorChannel Partner/ Reseller/ Distributor · 18 December 2025Optum Rx partnered with three additional PSAOs representing more than 17,000 pharmacies to achieve 100% transition to cost-based contracts across its network.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

OptumRx competitors and assessment

Company assessment

Direct peers

  • CVS Caremark (CVS Health): CVS Caremark is one of the Big Three PBMs alongside OptumRx, serving comparable employer, health plan, and government clients with formulary management, mail order, and specialty pharmacy services. It is the most direct competitor given nearly identical scale, customer mix, and integrated retail-pharmacy footprint.
  • Express Scripts (Cigna Group): Express Scripts is the third member of the Big Three PBMs, offering the same core PBM services as OptumRx — formulary management, home delivery, specialty pharmacy, and claims processing. Recently settled with the FTC on insulin pricing allegations, making it the closest regulatory and competitive peer to OptumRx.
  • Humana Pharmacy Solutions: Humana Pharmacy Solutions is the in-house PBM for Humana, primarily serving Medicare Advantage and Part D members. Comparable to OptumRx's government-sponsored segment with overlapping formulary management, prior authorization, and specialty pharmacy capabilities.
  • Prime Therapeutics: Prime Therapeutics is a PBM owned by a consortium of Blue Cross Blue Shield plans, serving health plan clients with formulary and clinical management similar to OptumRx's offerings. Its Blue-affiliated ownership makes it a strong structural peer for health plan-sponsored PBM services.
  • MedImpact Healthcare Systems: MedImpact is an independent PBM serving health plans, employers, and government programs with transparent pricing models. Its independence and early transparency positioning make it a direct alternative to OptumRx's fee-based model for clients seeking non-vertically-integrated PBM services.
  • Navitus Health Solutions: Navitus is a PBM focused on transparent, pass-through pricing for health plans, employers, and government programs. It competes with OptumRx for clients seeking alternatives to opaque rebate retention models, making it a relevant competitive peer in the transparency segment.
  • Elixir Rx Solutions: Elixir Rx Solutions is a PBM offering formulary management, mail order pharmacy, and specialty pharmacy services to health plans and employer clients. Comparable to OptumRx in core PBM functionality but at smaller scale, serving as a relevant niche competitor.

Emerging players

  • Capital Rx: Capital Rx is a tech-forward PBM offering a transparent, claims-processing platform (JUDI) for employers, unions, and TPAs. It represents an emerging competitive threat with a technology-native approach to PBM administration that contrasts with OptumRx's vertically integrated model.
  • SmithRx: SmithRx is a fast-growing, technology-led transparent PBM focused on small and mid-sized employers. While smaller in scale, its modern technology stack and transparent pricing compete directly with OptumRx for the same employer-sponsored book of business OptumRx is courting with its new fee-based model.

Broad incumbents

  • Amazon Pharmacy: Amazon Pharmacy is a broad retail and digital pharmacy entrant that has expanded into direct prescription delivery and integrated Amazon One Medical offerings. It does not yet operate as a full PBM but represents a strategic adjacent competitor to OptumRx's home delivery and consumer-facing pharmacy business.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

OptumRx social profiles

Digital presence

OptumRx compliance and trust

Trust signal

Compliance7 records

OptumRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OptumRx leadership team

Management profile

Number of profiles

Profiles4 records

OptumRx funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OptumRx M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OptumRx

What does OptumRx do?

OptumRx is a pharmacy benefit manager (PBM) that administers prescription drug coverage, formulary design, claims processing, and clinical pharmacy programs for health plans, employers, unions, government programs, and individual members. The company dispenses approximately 1.7 billion prescriptions annually through a network that includes home delivery, specialty, infusion, and retail pharmacy channels, supporting nearly 61 million members. OptumRx also offers specialty pharmacy care for complex conditions, prior authorization automation, and AI-driven fraud detection services.

Is OptumRx a public or private company?

OptumRx is a private company. It is classified as corporate owned and is currently operating.

When was OptumRx founded?

OptumRx was founded in 2026. It employs 1 to 10 people.

Where is OptumRx based?

OptumRx is headquartered in Irvine, United States, in the North America region.

How does OptumRx make money?

Four revenue lines are on record. Rebate Retention is the primary driver. The others are spread Pricing, fee-Based Model (New) and pharmacy Network Fees.

Who are OptumRx's main competitors?

Direct peers on record are CVS Caremark (CVS Health), Express Scripts (Cigna Group), Humana Pharmacy Solutions, Prime Therapeutics, MedImpact Healthcare Systems, Navitus Health Solutions and Elixir Rx Solutions. Emerging players are Capital Rx and SmithRx. Amazon Pharmacy is listed as a broad incumbent.

Does OptumRx have an API?

No public API is recorded for OptumRx.

What industry is OptumRx in?

OptumRx's product category is Pharmacy Benefit Management. Its primary akta.pro industry code is HLAEAKAA, Formulary Management & Clinical Pharmacy Programs, with a secondary code of HLAEAKAL, PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools). Its NAICS code is 524292 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Beckershospitalreview4 top PBMs now control 75% of market: 6 notesA September 2026 AMA analysis of PBM and insurer market shares from 2022 to 2024 found the four largest PBMs controlled 75% of the national market, up from 70% in 2022. OptumRx led with 23% rebate-negotiation share, and 69% of PDP lives were covered by vertically integrated insurers. The AMA raised antitrust concerns over concentration and integration.FierceHealthcare4 largest PBMs control 75% of U.S. market, AMA findsThe American Medical Association found the four largest U.S. pharmacy benefit managers controlled 75% of the national market in 2024, up from 70% in 2022. Concentration rose from 82% to 94% due to federal antitrust thresholds, with UnitedHealth's OptumRx and Express Scripts leading. The report calls for greater transparency and scrutiny of PBM market power.Milwaukee Journal SentinelJohn Oliver mentions Appleton man who died after he couldn't afford inhalerJohn Oliver discussed Cole Schmidtknecht, a 22-year-old Appleton man who died after his asthma inhaler was dropped from insurance coverage due to cost. His family sued Walgreens and OptumRx, alleging negligence; the case is set for trial no sooner than spring 2027. A proposed bill, Cole's Act, failed to pass in 2025.Green Bay Press-GazetteJohn Oliver mentions Appleton man who died after he couldn't afford inhalerJohn Oliver discussed Cole Schmidtknecht, a 22-year-old Appleton man who died after his asthma inhaler was dropped from insurance coverage, leaving him unable to afford it. His family sued Walgreens and OptumRx, alleging negligence; the case is set for trial no sooner than spring 2027. A proposed bill, Cole's Act, failed to pass in 2025.BeckershospitalreviewClosing the transparency gap: How Interra Health and OptumRx are working to put patients in control of medication costs - Becker's Hospital Review | Healthcare News & AnalysisAt a recent Becker's Healthcare webinar, executives from Interra Health and OptumRx discussed how real-time benefit tools and e-prescribing transparency are evolving to give patients greater visibility into medication costs before reaching the pharmacy. Interra Health processes approximately 3 million prescriptions monthly using NDC normalization to ensure accurate cost and coverage information, while OptumRx reported pricing accuracy within a penny of final cost 93% of the time. Both companies emphasized that extending cost transparency from providers to patients, pharmacists, and care coordinators is the next phase in creating a more connected, patient-centered medication experience.The National Law ReviewFTC–Caremark Settlement Expands PBM Insulin Pricing ReformsThe Federal Trade Commission announced a settlement with Caremark Rx, LLC and Zinc Health Services, LLC on July 14, 2026, to resolve claims that the pharmacy benefit managers used anticompetitive rebate schemes that artificially inflated insulin prices. The Caremark Order requires reforms including delinking manufacturer compensation from drug list prices, implementing caps on patient insulin out-of-pocket costs, and increasing transparency for plan sponsors. This marks the second settlement in the FTC's ongoing litigation against the nation's three largest PBMs, with OptumRx, Inc. remaining as the sole unresolved defendant.Healthcare DiveCourt dismisses PBMs’ lawsuit against FTC following insulin settlementsThe 8th Circuit Court of Appeals dismissed pharmacy benefit managers' countersuit against the FTC after Express Scripts, Caremark and OptumRx elected to settle with antitrust regulators over allegations they inflated insulin costs. The FTC sued the three PBMs in late 2024 for preferring expensive insulin products to generate higher rebates from pharmaceutical companies. Express Scripts' settlement requires delinking compensation from drug savings and increasing transparency, with the FTC projecting up to $7 billion in patient savings over a decade.YahooUnitedHealth (UNH) Takes Major Step Toward Resolving FTC Insulin Pricing DisputeOn June 12, UnitedHealth Group subsidiaries OptumRx and Emisar Pharma Services reached an agreement with the Federal Trade Commission to settle allegations of anticompetitive and unfair rebating practices related to insulin drug pricing. The FTC ordered all proceedings involving the Optum respondents to be stayed pending review of a proposed consent agreement that would fully resolve the claims. Separately, JPMorgan raised its price target on UnitedHealth Group to $466 from $420 while maintaining an Overweight rating, reflecting continued confidence in the company's long-term earnings potential.ForbesWeight Loss Drugs Listed By Health Insurers Aren’t Necessarily CoveredEli Lilly announced that its obesity medicines Zepbound and Foundayo will be listed on the formularies of all three major pharmacy benefit managers (OptumRx, Express Scripts, and CVS Caremark), yet actual insurance coverage remains uncertain because plan sponsors—not PBMs—ultimately control which drugs are covered for their members. Many employers and public programs are actually pulling back on weight-loss drug coverage, and a federal initiative (the BALANCE model) to expand Medicare access has stalled due to insufficient health plan participation. To address affordability barriers, both Eli Lilly and Novo Nordisk are offering lower-priced direct-to-consumer options ranging from $149 to $449 per month, though nearly 54% of patients still report cost challenges despite these options.DrugPatentWatchThe PBM Endgame: What Mark Cuban Got Right (and Pharma Is Still Ignoring)The Federal Trade Commission filed a lawsuit in September 2024 against the three largest U.S. pharmacy benefit managers—CVS Caremark, Express Scripts, and OptumRx—alleging that their formulary practices artificially inflated insulin prices by favoring high-list-price products to maximize rebate revenue, marking the most significant federal enforcement action against the PBM industry in its 50-year history. The three PBM conglomerates control approximately 80% of U.S. prescription drug claims and generate an estimated $100 billion to $150 billion annually through opaque rebate retention, spread pricing, and self-referral to their affiliated pharmacies, a system that has faced growing legislative and market pressure. Pharmaceutical manufacturers remain structurally dependent on the rebate system they publicly criticize, though some—including Eli Lilly's 70% insulin price cut in March 2023 and Novo Nordisk's direct-to-patient Wegovy program—have begun exploring direct-to-patient distribution models as regulatory and competitive disruption intensifies.